Pyridam Farma Tbk (PYFA) - Total Liabilities
Based on the latest financial reports, Pyridam Farma Tbk (PYFA) has total liabilities worth Rp6.19 Trillion IDR (≈ $362.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pyridam Farma Tbk - Total Liabilities Trend (2001–2024)
This chart illustrates how Pyridam Farma Tbk's total liabilities have evolved over time, based on quarterly financial data. Check Pyridam Farma Tbk (PYFA) asset resilience to evaluate the company's liquid asset resilience ratio.
Pyridam Farma Tbk Competitors by Total Liabilities
The table below lists competitors of Pyridam Farma Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kross Ltd
NSE:KROSS
|
India | Rs1.49 Billion |
|
Motorcycle Holdings Ltd
AU:MTO
|
Australia | AU$236.97 Million |
|
Limes Schlosskliniken AG
XETRA:LIK
|
Germany | €20.16 Million |
|
Emmerson Resources Ltd
AU:ERM
|
Australia | AU$591.50K |
|
SHL Consolidated Bhd
KLSE:6017
|
Malaysia | RM97.11 Million |
|
Eastern Communications Co Ltd B
SHG:900941
|
China | $847.86 Million |
|
ROKISKIO SURIS PC EO 029
F:YTV
|
Germany | €62.27 Million |
|
Astron Corporation Ltd
AU:ATR
|
Australia | AU$12.77 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down Pyridam Farma Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PYFA current and non-current assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 8.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.89 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pyridam Farma Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pyridam Farma Tbk (2001–2024)
The table below shows the annual total liabilities of Pyridam Farma Tbk from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp4.77 Trillion ≈ $279.59 Million |
+309.87% |
| 2023-12-31 | Rp1.16 Trillion ≈ $68.22 Million |
+7.97% |
| 2022-12-31 | Rp1.08 Trillion ≈ $63.18 Million |
+68.70% |
| 2021-12-31 | Rp639.12 Billion ≈ $37.45 Million |
+800.89% |
| 2020-12-31 | Rp70.94 Billion ≈ $4.16 Million |
+7.39% |
| 2019-12-31 | Rp66.06 Billion ≈ $3.87 Million |
-3.04% |
| 2018-12-31 | Rp68.13 Billion ≈ $3.99 Million |
+34.36% |
| 2017-12-31 | Rp50.71 Billion ≈ $2.97 Million |
-17.62% |
| 2016-12-31 | Rp61.55 Billion ≈ $3.61 Million |
+4.81% |
| 2015-12-31 | Rp58.73 Billion ≈ $3.44 Million |
-22.17% |
| 2014-12-31 | Rp75.46 Billion ≈ $4.42 Million |
-7.09% |
| 2013-12-31 | Rp81.22 Billion ≈ $4.76 Million |
+68.70% |
| 2012-12-31 | Rp48.14 Billion ≈ $2.82 Million |
+35.10% |
| 2011-12-31 | Rp35.64 Billion ≈ $2.09 Million |
+52.54% |
| 2010-12-31 | Rp23.36 Billion ≈ $1.37 Million |
-13.19% |
| 2009-12-31 | Rp26.91 Billion ≈ $1.58 Million |
-8.47% |
| 2008-12-31 | Rp29.40 Billion ≈ $1.72 Million |
+4.21% |
| 2007-12-31 | Rp28.21 Billion ≈ $1.65 Million |
+57.38% |
| 2006-12-31 | Rp17.93 Billion ≈ $1.05 Million |
+37.06% |
| 2005-12-31 | Rp13.08 Billion ≈ $766.41K |
+57.83% |
| 2004-12-31 | Rp8.29 Billion ≈ $485.58K |
+9.67% |
| 2003-12-31 | Rp7.56 Billion ≈ $442.77K |
-21.76% |
| 2002-12-31 | Rp9.66 Billion ≈ $565.95K |
-40.17% |
| 2001-12-31 | Rp16.14 Billion ≈ $945.96K |
-- |
About Pyridam Farma Tbk
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extra… Read more